Coxsackievirus B epidemiology and public health concerns

Current Topics in Microbiology and Immunology

Volumn 223, Issue 1, 1997, Pages 13-30

  Pallansch, M A ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COXSACKIE VIRUS B; HUMAN; INFECTION CONTROL; PRIORITY JOURNAL; REVIEW; SEROLOGY; VIRUS INFECTION;

COXSACKIEVIRUS; COXSACKIEVIRUS B; HUMAN ENTEROVIRUS B;

EID: 0030816161     PISSN: 0070217X     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-642-60687-8_2     Document Type: Review

References (10)

1. Alexander JP Jr, Chapman LE, Pallansch MA, Stephenson WT, Török TJ, Anderson LJ (1993) Coxsackievirus B2 infection and aseptic meningitis: a focal outbreak among members of a high school football team. J Infect Dis 167:1201-1205
2. Argo E, Gimenez B, Cash P (1992) Non-cytopathic infection of rhabdomyosarcoma cells by coxsackie B5 virus. Arch Virol 126:215-229
3. Axelsson C, Bondestam K, Frisk G, Bergström S, Diderholm H (1993) Coxsackie B virus infections in women with miscarriage. J Med Virol 39:282-285
4. Barrett-Conner E (1985) Is insulin-dependent diabetes mellitus caused by coxsackievirus B infection? A review of the epidemiologic evidence. Rev Infect Dis 7:207-215
5. Tuvemo T, Dahlquist G, Frisk G, Blom L, Friman G, Landin-Olsson M, Diderholm H (1989) The Swedish childhood diabetes study III: IgM against coxsackie B viruses in newly diagnosed type 1 (insulin-dependent) diabetic children - no evidence of increased antibody frequency. Diabetologia 32:745-747
6. Wagenknecht LE, Roseman JM, Herman WH (1991) Increased incidence of insulin-dependent diabetes mellitus following an epidemic of Coxsackievirus B5. Am J Epidemiol 133:1024-1031
7. Yagi S, Schnurr D, Lin J (1992) Spectrum of monoclonal antibodies to coxsackievirus B-3 includes type- and group-specific antibodies. J Clin Microbiol 30:2498-2501
8. Yui LA, Gledhill RF (1991) Limb paralysis as a manifestation of Coxsackie B virus infection. Dev Med Child Neurol 33:427-438
9. Zoll J, Galama J, Melchers W (1994) Intratypic genome variability of the coxsackievirus B1 2A protease region. J Gen Virol 75:687-692
10. Zoll J, Jongen P, Galama J, van Kuppeveld F, Melchers W (1993) Coxsackievirus B1-induced murine myositis: no evidence for viral persistence. J Gen Virol 74:2071-2076